Sanctuary Advisors LLC Makes New $260,000 Investment in HealthEquity, Inc. (NASDAQ:HQY)

Sanctuary Advisors LLC bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) in the 3rd quarter, Holdings Channel reports. The firm bought 3,176 shares of the company’s stock, valued at approximately $260,000.

A number of other hedge funds have also recently modified their holdings of HQY. Wasatch Advisors LP lifted its stake in shares of HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after acquiring an additional 483,269 shares during the last quarter. State Street Corp lifted its position in shares of HealthEquity by 0.8% during the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after purchasing an additional 23,613 shares during the last quarter. Clearbridge Investments LLC boosted its stake in shares of HealthEquity by 1.9% during the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock valued at $204,915,000 after purchasing an additional 43,491 shares during the period. Mackenzie Financial Corp grew its holdings in shares of HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after purchasing an additional 325,906 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in HealthEquity by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock worth $170,197,000 after buying an additional 15,145 shares during the period. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Royal Bank of Canada boosted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. Bank of America boosted their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. JMP Securities raised their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Finally, The Goldman Sachs Group started coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $110.71.

Read Our Latest Stock Report on HQY

Insider Activity at HealthEquity

In other news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the transaction, the director now owns 66,469 shares in the company, valued at $6,750,591.64. This represents a 11.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,786 shares of company stock valued at $4,140,387 over the last 90 days. Insiders own 2.20% of the company’s stock.

HealthEquity Stock Down 1.1 %

NASDAQ:HQY opened at $96.30 on Friday. The company’s 50-day simple moving average is $95.99 and its 200-day simple moving average is $85.03. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $105.82. The stock has a market capitalization of $8.35 billion, a P/E ratio of 88.35, a P/E/G ratio of 1.10 and a beta of 0.55.

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.